Injectafer Lawsuits For Hypophosphatemia / Electrolyte Disorders Leading To Other Serious Medical Complications
In a rush? You can use our Quick Contact Form to tell us the basic information about your case.
Injectafer is an iron replacement injection used for the treatment of iron deficiency anemia (IDA) since approved by the FDA in 2013. More recently, Injectafer has been associated with hypophosphatemia (HPP), potentially leading to other related serious medical complications, such as osteomalacia, arrhythmias, cardiac arrest, respiratory failure, and rhabdomyolysis. In turn, Injectafer lawsuits are being filed against the manufacturers of Injectafer, alleging a failure to adequately warn doctors and patients about Injectafer side effects.
Injectafer side effects include these two relatively rare conditions:
- Hypophosphatemia (HPP)
- Severe Hypophosphatemia (Severe HPP)
These two conditions are electrolyte disorders in which there is a low level of phosphate in the blood. Symptoms may include weakness, trouble breathing, and loss of appetite.
In turn, Injectafer-related hypophosphatemia can lead to serious medical complications including:
- Cardiac Arrest
- Respiratory Failure
Our law firm is investigating possible Injectafer lawsuits where patients have suffered Injectafer side effects.
Free Injectafer Case Evaluation
We encourage you to submit an Injectafer Case Evaluation Form online – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions – not an intake person, a paralegal, nor some other lawyer – about your case based on his many years of experience.
Most Recent Article About Injectafer
Injectafer Drug Label Change Adds New Hypophosphatemia Warning
There was an Injectafer drug label change in February 2020 which added a new hypophosphatemia warning. Most importantly, the Warnings and Precautions part of the Injectafer drug label added a new subsection 5.2 titled “Symptomatic Hypophosphatemia”.
To read more of this article, click below:
Some background about the new hypophosphatemia warning for Injectafer can be found in these two recent articles:
- Our February 3, 2020 Drug Injury Watch blog post, “Injectafer-Induced Hypophosphatemia Can Be A Serious Side Effect Of This Iron Deficiency Anemia Drug”; and,
- Our February 11, 2020 Drug Injury Watch blog post, “Hypophosphatemia As A Side Effect Of Injectafer vs. Monoferric Treatments: Comparisons From Two Clinical Trials”.
Severe hypophosphatemia can cause Injectafer-related medical complications including but not limited to:
We are investigating possible Injectafer drug injury lawsuits for patients and their families.[Read article in full at original source]
Earlier articles about Injectafer by attorney Tom Lamb on the Side Effects Blog:
- Hypophosphatemia Associated With Injectafer Compared To Another Intravenous Drug
- Hypophosphatemia Is An Injectafer Side Effect With Possible Serious Medical Complications Including Death